Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma

Journal of Pathology

Volumn 193, Issue 3, 2001, Pages 318-324

  De Jong, Daphne ^a   Vyth Dreese, Florry ^a   Dellemijn, Trees ^a   Verra, Natascha ^a   Ruskoné Fourmestraux, Agnes ^a   Lavergne Slove, Anne ^b   Hart, Guus ^c   Boot, Henk ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b HÔTEL DIEU   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Co stimulatory markers; Gastric lymphoma; H. pylori; Histological grading; Prognostic factors

Indexed keywords

ANTIBIOTIC AGENT; ANTIGEN; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; LIGAND; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BLAST CELL; CANCER GRADING; CANCER REGRESSION; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL PARAMETERS; MALE; MORPHOLOGY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH MUCOSA; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0035097752     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH811>3.0.CO;2-Z     Document Type: Article

References (35)

1. Immunological aspects of Helicobacter pylori infection and malignant transformation of B-cells
2. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
3. Helicobacter pylori-specific tumour-infiltrating T-cells provide contact dependent help for the growth of malignant B-cells in low-grade gastric lymphomas of mucosa-associated lymphoid tissue
4. Regression of primary low-grade B-cell gastrointestinal lymphoma of mucosa associated lymphoid tissue type after eradication of Helicobacter pylori
5. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue after cure of Helicobacter pylori infection
6. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue
7. Regression of primary gastric low-grade MALT lymphoma after cure of Helicobacter pylori infectior - German MALT lymphoma trial
8. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma
9. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma
10. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging
11. Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance
12. Low-grade B-cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signalling and Th2-type cytokines for in vitro growth and differentiation
13. Analysis of TH1 and TH2 cytokine production in low-grade B-cell gastric MALT-type lymphomas stimulated in vitro with Helicobacter pylori
14. Characterization of tumour-infiltrating T-lymphocytes in B-cell lymphomas of mucosa-associated lymphoid tissue
15. The role of B7-1/B7-2: CD28/CTLA4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response
16. The CD40 antigen and its ligand
17. Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumour immunogenicity
18. Functional expression of adhesion receptors and costimulatory molecules by fresh and immortalized B-cell non-Hodgkin's lymphoma cells
19. In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation
20. Klinische Stadieneinteilung der Nicht-Hodgkin lymphome
21. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection
22. In situ localization of costimulatory molecules in normal lymphoid tissue
23. Adjusted P-values for simultaneous inference
24. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey
25. Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma
26. Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MAL Toma
27. Replication error phenotype and p53 mutation in lymphomas of mucosa-associated lymphoid tissue
28. Cytogenetic study of B-cell lymphomas of mucosa-associated lymphoid tissue
29. Bc110 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumour types
30. Functional characterization of a novel anti-B7 monoclonal antibody
31. B70 antigen is a second ligand for CTLA-4 and CD28
32. Functional properties of the human T-cell differentiation antigen CD28
33. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T-lymphocytes
34. Activation of human B lymphocytes through CD40 and interleukin 4
35. + T cells that induces contact-dependent B cell differentiation